Search

Your search keyword '"Puglisi, A."' showing total 408 results

Search Constraints

Start Over You searched for: Author "Puglisi, A." Remove constraint Author: "Puglisi, A." Publisher elsevier ltd Remove constraint Publisher: elsevier ltd
408 results on '"Puglisi, A."'

Search Results

1. Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study

2. Soundscape descriptors in eighteen languages: Translation and validation through listening experiments

3. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

4. Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

8. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review

13. Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients

15. Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials

20. Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

25. Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread

26. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

35. Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial

39. Reliability of patient-reported toxicities during adjuvant chemotherapy

40. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

43. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

47. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

Catalog

Books, media, physical & digital resources